Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction

Nirali N. Shah; Jennifer Schneiderman; Denison Kuruvilla; Deepa Bhojwani; Terry J. Fry; Paul L. Martin; Kirk R. Schultz; Lewis B. Silverman; James A. Whitlock; Brent Wood; Inna Vainshtein; Alexia Adams; Dennis Confer; Michael A. Pulsipher; Sonali Chaudhury; Alan S. Wayne

doi:10.1002/pbc.28574

Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction

Nirali N. Shah^*, Jennifer Schneiderman, Denison Kuruvilla, Deepa Bhojwani, Terry J. Fry, Paul L. Martin, Kirk R. Schultz, Lewis B. Silverman, James A. Whitlock, Brent Wood, Inna Vainshtein, Alexia Adams, Dennis Confer, Michael A. Pulsipher, Sonali Chaudhury, Alan S. Wayne

^*Corresponding author for this work

Pediatrics

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Article number	e28574
Journal	Pediatric Blood and Cancer
Volume	68
Issue number	1
DOIs	https://doi.org/10.1002/pbc.28574
State	Published - Jan 2021

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Hematology
Oncology

Access to Document

10.1002/pbc.28574

Cite this

Shah, N. N., Schneiderman, J., Kuruvilla, D., Bhojwani, D., Fry, T. J., Martin, P. L., Schultz, K. R., Silverman, L. B., Whitlock, J. A., Wood, B., Vainshtein, I., Adams, A., Confer, D., Pulsipher, M. A., Chaudhury, S., & Wayne, A. S. (2021). Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction. Pediatric Blood and Cancer, 68(1), Article e28574. https://doi.org/10.1002/pbc.28574

@article{68c6886947c741bb9ca184389118a32a,

title = "Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction",

author = "Shah, {Nirali N.} and Jennifer Schneiderman and Denison Kuruvilla and Deepa Bhojwani and Fry, {Terry J.} and Martin, {Paul L.} and Schultz, {Kirk R.} and Silverman, {Lewis B.} and Whitlock, {James A.} and Brent Wood and Inna Vainshtein and Alexia Adams and Dennis Confer and Pulsipher, {Michael A.} and Sonali Chaudhury and Wayne, {Alan S.}",

note = "Funding Information: This trial was supported in part by the Intramural Research Program, National Cancer Institute and NIH Clinical Center, National Institutes of Health, MedImmune, 2UG1HL069254 (NHLBI/NCI), the Johnny Crisstopher Children's Charitable Foundation St. Baldrick's Consortium Grant and by NCI award P30CA014089.",

year = "2021",

month = jan,

doi = "10.1002/pbc.28574",

language = "English (US)",

volume = "68",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "1",

}

Shah, NN, Schneiderman, J, Kuruvilla, D, Bhojwani, D, Fry, TJ, Martin, PL, Schultz, KR, Silverman, LB, Whitlock, JA, Wood, B, Vainshtein, I, Adams, A, Confer, D, Pulsipher, MA, Chaudhury, S & Wayne, AS 2021, 'Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction', Pediatric Blood and Cancer, vol. 68, no. 1, e28574. https://doi.org/10.1002/pbc.28574

TY - JOUR

T1 - Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction

AU - Shah, Nirali N.

AU - Schneiderman, Jennifer

AU - Kuruvilla, Denison

AU - Bhojwani, Deepa

AU - Fry, Terry J.

AU - Martin, Paul L.

AU - Schultz, Kirk R.

AU - Silverman, Lewis B.

AU - Whitlock, James A.

AU - Wood, Brent

AU - Vainshtein, Inna

AU - Adams, Alexia

AU - Confer, Dennis

AU - Pulsipher, Michael A.

AU - Chaudhury, Sonali

AU - Wayne, Alan S.

N1 - Funding Information: This trial was supported in part by the Intramural Research Program, National Cancer Institute and NIH Clinical Center, National Institutes of Health, MedImmune, 2UG1HL069254 (NHLBI/NCI), the Johnny Crisstopher Children's Charitable Foundation St. Baldrick's Consortium Grant and by NCI award P30CA014089.

PY - 2021/1

Y1 - 2021/1

UR - http://www.scopus.com/inward/record.url?scp=85091287454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85091287454&partnerID=8YFLogxK

U2 - 10.1002/pbc.28574

DO - 10.1002/pbc.28574

M3 - Letter

C2 - 32959985

AN - SCOPUS:85091287454

SN - 1545-5009

VL - 68

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - 1

M1 - e28574

ER -

Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this